VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 68 filers reported holding VERRICA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 8.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $532,191 | -31.9% | 136,986 | +1.2% | 0.03% | -28.3% |
Q2 2023 | $781,033 | -11.2% | 135,361 | 0.0% | 0.05% | -23.3% |
Q1 2023 | $879,847 | +134.6% | 135,361 | -0.7% | 0.06% | +114.3% |
Q4 2022 | $374,993 | -4.6% | 136,361 | +1.3% | 0.03% | -3.4% |
Q3 2022 | $393,000 | +51.7% | 134,661 | 0.0% | 0.03% | +52.6% |
Q2 2022 | $259,000 | -76.1% | 134,661 | +0.9% | 0.02% | -68.9% |
Q1 2022 | $1,082,000 | -11.3% | 133,411 | +0.2% | 0.06% | -11.6% |
Q4 2021 | $1,220,000 | -26.7% | 133,211 | +0.0% | 0.07% | -37.3% |
Q3 2021 | $1,665,000 | +10.9% | 133,161 | +0.2% | 0.11% | +4.8% |
Q2 2021 | $1,502,000 | -25.4% | 132,961 | 0.0% | 0.10% | -34.0% |
Q1 2021 | $2,014,000 | +31.6% | 132,961 | 0.0% | 0.16% | +14.4% |
Q4 2020 | $1,530,000 | +48.7% | 132,961 | 0.0% | 0.14% | +26.4% |
Q3 2020 | $1,029,000 | -29.4% | 132,961 | +0.5% | 0.11% | -40.2% |
Q2 2020 | $1,457,000 | +0.7% | 132,361 | 0.0% | 0.18% | -19.7% |
Q1 2020 | $1,447,000 | -31.2% | 132,361 | 0.0% | 0.23% | -21.0% |
Q4 2019 | $2,103,000 | – | 132,361 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 108,794 | $1,252,000 | 0.47% |
Perceptive Advisors | 3,410,412 | $39,254,000 | 0.42% |
KNOTT DAVID M | 76,585 | $881,000 | 0.40% |
Fosun International Ltd | 324,061 | $3,730,000 | 0.24% |
Orbimed Advisors | 1,479,733 | $17,032,000 | 0.15% |
SteelPeak Wealth, LLC | 132,961 | $1,530,000 | 0.14% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 665,511 | $7,660,000 | 0.13% |
Capital Investment Advisory Services, LLC | 15,125 | $174,000 | 0.03% |
BECK MACK & OLIVER LLC | 10,000 | $115,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 335,318 | $3,860,000 | 0.00% |